Alkermes
ALKS
#3173
Rank
S$6.04 B
Marketcap
S$36.61
Share price
0.11%
Change (1 day)
-9.21%
Change (1 year)

Market capitalization of Alkermes (ALKS)

Market cap: S$6.04 Billion

As of December 2025 Alkermes has a market cap of S$6.04 Billion. This makes Alkermes the world's 3173th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alkermes from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025S$6.04 B-7%
2024S$6.49 B6.3%
2023S$6.11 B6.22%
2022S$5.75 B13.19%
2021S$5.08 B21.06%
2020S$4.20 B-3.2%
2019S$4.33 B-30.89%
2018S$6.27 B-44.22%
2017S$11.25 B-7.92%
2016S$12.22 B-27.76%
2015S$16.92 B48.22%
2014S$11.41 B60.83%
2013S$7.09 B136.69%
2012S$2.99 B2.94%
2011S$2.91 B93.2%
2010S$1.50 B20.89%
2009S$1.24 B-13.95%
2008S$1.44 B-35.62%
2007S$2.25 B8.76%
2006S$2.06 B-29.03%
2005S$2.91 B40.48%
2004S$2.07 B1.62%
2003S$2.04 B189.49%
2002S$0.70 B-77.54%
2001S$3.14 B0.93%
2000S$3.11 B49.13%
1999S$2.08 B169.21%
1998S$0.77 B10.89%
1997S$0.69 B16.07%
1996S$0.60 B

End of Day market cap according to different sources

On Dec 24th, 2025 the market cap of Alkermes was reported to be:

S$6.03 Billion
by Nasdaq info icon info icon
S$6.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Acorda Therapeutics
ACOR
S$1.05 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$142.95 B 2,265.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$642.52 B 10,530.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$182.65 B 2,922.06%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$367.91 B 5,987.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$46.73 B 673.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
S$1.92 B-68.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$150.38 B 2,388.04%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
S$342.02 B 5,558.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland